C4 Therapeutics Inc
NASDAQ:CCCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
Core Scientific Inc
NASDAQ:CORZ
|
US |
|
C
|
Canal+ SA
OTC:CNALF
|
FR |
|
A
|
Advanced Information Technology Public Company Limited
SET:AIT
|
TH |
|
S
|
Sekisui Chemical Co Ltd
XBER:SUI
|
JP |
|
V
|
Visteon Corp
F:VS51
|
US |
|
K
|
KBC Groep NV
DUS:KDB
|
BE |
|
Diversified Energy Co
F:QI7
|
US |
|
I
|
Industrie De Nora SpA
MIL:DNR
|
IT |
|
B
|
Balchem Corp
F:BL9B
|
US |
|
SET:PSP
|
TH | |
|
United & Collective Co Ltd
TSE:3557
|
JP |
|
Accrol Group Holdings PLC
LSE:ACRL
|
UK |
|
K
|
Karnov Group AB (publ)
F:3UA
|
SE |
|
First Solar Inc
LSE:0R06
|
US |
|
S
|
Sword Group SE
SWB:9RS
|
LU |
|
Tongwei Co Ltd
SSE:600438
|
CN |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
Critical Metals Corp
F:9O2
|
AU |
|
C
|
Cardinal Health Inc
SWB:CLH
|
US |
|
Entera Bio Ltd
NASDAQ:ENTX
|
IL |
|
A
|
ALT Telecom PCL
SET:ALT
|
TH |
|
A
|
Aristocrat Leisure Ltd
SWB:AC8
|
AU |
|
M
|
MGM Resorts International
XMUN:MGG
|
US |
Bankruptcy Probability
C4 Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
C4 Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
375.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
C4 Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, C4 Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
